Cargando…
Search of ligands suitable for (212)Pb/(212)Bi in vivo generators
The short half-life of (212)Bi and (213)Bi limits the application of these radionuclides in α radionuclide therapy. The labeling of biomolecules with (212)Pb (mother nuclide of (212)Bi) instead of (212)Bi or (213)Bi has the advantage of obtaining a conjugate with a half-life of 10.6 h, compared with...
Autores principales: | Bartoś, Barbara, Lyczko, Krzysztof, Kasperek, Agata, Krajewski, Seweryn, Bilewicz, Aleksander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4513904/ https://www.ncbi.nlm.nih.gov/pubmed/26224928 http://dx.doi.org/10.1007/s10967-012-2238-4 |
Ejemplares similares
-
Stability of (47)Sc-complexes with acyclic polyamino-polycarboxylate ligands
por: Połosak, Magdalena, et al.
Publicado: (2012) -
An Experimental Generator for Production of High-Purity (212)Pb for Use in Radiopharmaceuticals
por: Li, Ruth Gong, et al.
Publicado: (2023) -
(212)Pb: Production Approaches and Targeted Therapy Applications
por: Kokov, Konstantin V., et al.
Publicado: (2022) -
Production, purification, and radiolabeling of the (203)Pb/(212)Pb theranostic pair
por: McNeil, Brooke L., et al.
Publicado: (2021) -
Imaging of (212)Pb in mice with a clinical SPECT/CT
por: Kvassheim, Monika, et al.
Publicado: (2023)